Braveheart Bio (NASDAQ:BRVE) Releases Quarterly Earnings Results, Misses Expectations By $2.26 EPS
Braveheart Bio (NASDAQ:BRVE – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($2.51) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by ($2.26), Zacks reports. Braveheart Bio Stock Up 10.0% NASDAQ BRVE traded up $2.67 during midday trading on Tuesday, hitting $29.41. The company had […]
8 Sep 16:40 · The Cerbat Gem